ZLAB Q4 2025 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$128M+17.0% YoY

Gross Profit

$66M51.6% margin

Operating Income

-$69M-54.4% margin

Net Income

-$50M-39.5% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+9.9%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$457M

Stockholders' Equity

$716M

Cash & Equivalents

$680M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$128M	$109M	+17.0%
Gross Profit	$66M	$67M	-1.7%
Operating Income	-$69M	-$68M	-2.2%
Net Income	-$50M	-$82M	+38.3%

Revenue Segments

Zejula

$56M60%

Nuzyra

$16M17%

Optune

$12M13%

Qinlock

$10M10%